Expression of angiogenic factors is upregulated in DMBA-induced rat mammary pathologies

Pathobiology

Volumn 71, Issue 5, 2004, Pages 253-260

  Yan, Mei ^a   Schneider, Joanne ^a   Gear, Robin ^a   Lu, Fengxian ^a   LaDow, Kathy ^a   Warshawsky, David ^a   Heffelfinger, Sue C ^a,b  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

7,12 Dimethylbenz a anthracene; Angiogenesis; Breast cancer; Growth factor

Indexed keywords

3 BROMO 5 TERT BUTYL 4 HYDROXYBENZYLIDENEMALONONITRILE; ANGIOGENIC FACTOR; ANGIOPOIETIN 1; ANGIOPOIETIN 2; BASIC FIBROBLAST GROWTH FACTOR; DIMETHYLBENZ[A]ANTHRACENE; GELATINASE A; GELATINASE B; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; INSULIN RECEPTOR SUBSTRATE 1; MASPIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; SERINE PROTEINASE INHIBITOR; SOMATOMEDIN B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; SOMATOMEDIN RECEPTOR; THROMBOSPONDIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA; TYRPHOSTIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST DISEASE; CANCER INVASION; CARCINOGENESIS; CARCINOMA IN SITU; DOWN REGULATION; FEMALE; HYPERPLASIA; IN VITRO STUDY; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SECTION; UPREGULATION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANGIOGENIC PROTEINS; ANGIOPOIETIN-1; ANIMALS; CARCINOGENS; CARCINOMA IN SITU; CARCINOMA, DUCTAL; FEMALE; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HYPERPLASIA; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; OSTEONECTIN; PHOSPHOPROTEINS; PLASMINOGEN ACTIVATOR INHIBITOR 1; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THROMBOSPONDIN 1; URINARY PLASMINOGEN ACTIVATOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 3543151036     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080059     Document Type: Article

References (37)

1. Folkman J: How is blood vessel growth regulated in normal and neoplastic tissue? Cancer Res 1986;50:467-473.
2. Liekens S, Clercq E, Neyts J: Angiogenesis: Regulators and clinical significance. Biochem Pharmacol 2001;61:253-270.
3. Rice A, Quinn C: Angiogenesis, thrombospondin, and ductal carcinoma in situ. J Clin Pathol 2002;55:569-574.
4. Heffelfinger S, Yassin R, Miller M, Lower E: Vascularity of proliferative breast disease and carcinoma in situ correlates with histologic features. Clin Cancer Res 1996;2:1873-1878.
5. Ottinetti A, Sapino A: Morphometric evaluation of microvessels surrounding hyperplastic and neoplastic mammary lesions. Breast Cancer Res Treatm 1988;11:241-248.
6. Heffelfinger SC, Gear RB, Taylor K, Schneider J, LaDow K, Miller MA, Warshawsky D: DMBA-induced pre-invasive mammary tumors are angiogenic in vitro and in vivo. Lab Invest 2000;80:485-492.
7. Heffelfinger S, Gear R, Schneider J, LaDow K, Yan M, Lu F, Pyle A, Warshawsky D: TNP-470 inhibits DMBA-induced mammary tumor formation when administered prior to the formation of CIS but is not additive with tamoxifen. Lab Invest 2003;83:1001-1011.
8. Russo J, Gusterson B, Rogers A, Russo I, Wellings S, van Zwieten M: Biology of Disease: Comparative study of human and rat mammary tumorigenesis. Lab Invest 1990;62:244-278.
9. Venetsanakos E, Beckman I, Bradley J, Skinner J: High incidence of interleukin 10 mRNA but not interleukin 2 mRNA detected in human breast tumors. Br J Cancer 1997;75:1826-1830.
10. Weinmann M, Thews O, Shroeder T, Vaupel P: Expression pattern of the urokinase-plasminogen activator system in rat DS-sarcoma: Role of oxygenation status and tumor size. Br J Cancer 2002;86:1355-1361.
11. Xu G, Sima A: Altered immediate early gene expression in injured diabetic nerve: Implications in regeneration. J Neuropathol Esp Neurol 2001;60:972-983.
12. Park J, Borer J, Freeman M, Peters C: Stretch activates heparin-binding EGF-like growth factor expression in bladder smooth muscle cells. Am J Physiol Cell Physiol 1998;275:C1247-C1254.
13. Tso J, Sun X, Kao T: Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: Genomic complexity and molecular evolution of the gene. Nucl Acid Res 1985;13:2485-2502.
14. Parrizas M, Gazit A, Levitzki A, Wertheimer E, Leroith D: Specific inhibition of insulin-like growth factor-1 and insulin receptor tyrosine kinase activity and biological function by tyrphostins. Endocrinology 1997;138:1427-1433.
15. Sage E, Vernon R: Regulation of angiogenesis by extracellular matrix: The growth and glue. J Hypertens 1994;12:S145-S152.
16. Heppner K, Matrisian L, Jensen R, Rodgers W: Expression of most matrix metalloproteinase family members in breast cancer represents a tumor induced host response. Am J Pathol 1996;149:273-282.
17. Bajou K, Noel A, Gerard R, Masson V, Brunner N, Holst-Hansen C, Skobe M, Fusening N, Carmelot P, Collen D, et al: Absence of host plasminogen activator inhibitor I prevents cancer invasion and vascularization. Nat Med 1998;4:923-928.
18. Fox S, Taylor M, Grondahl-Hansen J, Kakolyris S, Gatter K, Harris A: Plasminogen activator inhibitor-I as a measure of vascular remodelling in breast cancer. J Pathol 2001;195:236-243.
19. Bajou K, Lewalle J, Martinex C, Soria C, Lu H, Noel A, Foidart J: Human breast adenocarcinoma cell lines promote angiogenesis by providing cells with uPA-PAI-1 and by enhancing their expression. Int J Cancer 2002;100:501-506.
20. Gomez D, Alonso D, Yoshiji H, Thorgeirsson U: Tissue inhibitors of metalloproteinases: Structure, regulation, and biological functions. Eur J Cancer 1997;74:111-122.
21. Motamed K: SPARC (osteonectin/BM-40). Int J Biochem Cell Biol 1999;31:1363-1366.
22. Isogai C, Laug W, Schmada H, Declerck P, Stins M, Durden K, Erdreich-Epstein A, DeClerck Y: Plasminogen activator inhibitor-1 promotes angiogenesis by stimulating endothelial cell migration toward fibronectin. Cancer Res 2001;61:5587-5594.
23. Guidi A, Schnitt S, Fisher L, Tognazzi K, Harns J, Dvorak H, Brown L: Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast. Cancer 1997;80:1945-1953.
24. Visscher D, DeMathia F, Ottosen S, Sarkar F, Crissman T: Biological and clinical significance of basic fibroblast growth factor immunostaining in breast carcinoma. Mod Pathol 1995;8:665-670.
25. Heffelfinger S, Miller M, Yassin R, Gear R: Angiogenic growth factors in pre-invasive breast disease. Clin Cancer Res 1999;5:2867-2876.
26. Maisonpierre P, Suri C, Jones P, Bartunkova S, Wiegand S, Radziejewski C, Compton D, McClain J, Aldrich T, Papadopoulos N, et al: Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997;277:55-60.
27. Iruela-Arispe M, Dvorak H: Angiogenesis: A dynamic balance of stimulators and inhibitors. Thromb Haemost 1997;78:672-277.
28. Zhang M, Volpert O, Shi Y, Bouck N: Maspin is an angiogenesis inhibitor. Nat Med 2000;6:196-199.
29. Currie M, Cunningham S, Han C, Scott P, Robinson B, Harris A: Angiopoietin-1 is inversely related to thymidine phosphorylase expression in human breast cancer, indicating a role in vascular remodeling. Clin Cancer Res 2001;7:918-927.
30. Maass N, Nagasaki K, Ziebert M, Mundhenke C, Jonat W: Expression and regulation of tumor suppressor gene maspin in breast cancer. Clin Breast Cancer 2002;3:281-287.
31. Bertin N, Clezardin P, Kubiak R, Frappart L: Thrombospondin-1 and -2 messenger RNA expression in normal, benign and neoplastic human breast tissues: Correlation with prognostic factors, tumor angiogenesis and fibroblastic desmoplasia. Cancer Res 1997;57:396-399.
32. Zabrenetsky V, Harris C, Steng P, Roberts D: Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma. Int J Cancer 1994;59:191-195.
33. Han R, Post M, Tanswell A, Lye S: Insulin-like growth factor-1 receptor-mediated vasculogenesis/angiogenesis in human lung development. Am J Respir Cell Mol Biol 2003;28:159-169.
34. Stoeltzing O, Liu W, Reinmuth N, Fan F, Parikh A, Bucana C, Evans D, Semeza G, Ellis L: Regulation of hypoxia inducible factor-1 alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-1 receptor autocrine loop in human pancreatic cancer. Am J Pathol 2003;163:1001-1011.
35. Reinmuth N, Fan F, Liu W, Parikh A, Stoeltzing O, Jung Y, Bucana C, Radinsky R, Gallick G, Ellis L: Impact of insulin-like growth factor receptor-1 function on angiogenesis, growth, and metastasis of colon cancer. Lab Invest 2002;82:1377-1389.
36. Shigematsu S, Yamauchi K, Nakajima K, Iijima S, Aizawa T, Hashizum K: IGF-1 regulates migration and angiogenesis of human endothelial cells. Endocr J 1999;46:S59-S62.
37. Baserga R, Peruzzi F, Reiss K: The IGF-1 receptor in cancer biology. Int J Cancer 2003;107:873-877.